Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bocchino, P. Chiaradonna, A. Matarese, M. Salvatores, M. G. Alma, A. Sanduzzi, A. M. Altieri (Naples, Rome, Italy). Performance of a commercial IFN-γ blood assay for monitoring treatment efficacy in active pulmonary tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 1694

Member's Comments

No comment yet.

Related content which might interest you: Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment. Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 Evaluation of patient adherence to tuberculosis treatment by measuring drug metabolites in urine Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004 The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Impact of mono- and poli-resistance on the treatment outcomes of pulmonary tuberculosis Source: International Congress 2017 – MDRTB: detection and management Year: 2017 Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1-3 Year: 2006 Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Screening and monitoring of tuberculosis in patients on biologics treatment Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Monitoring during and after tuberculosis treatment Source: Eur Respir Monogr 2018; 82: 308-325 Year: 2018 Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary tuberculosis; a clinical trial Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008 Evaluation of the efficacy and safety of levofloxacin in the treatment of resistant pulmonary tuberculosis; a clinical trial Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002 Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT) Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011 Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area Source: Eur Respir J 2004; 23: 446-451 Year: 2004 Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients Source: Eur Respir J 2003; 22: Suppl. 45, 521s Year: 2003 Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008